MICHAEL THOMAS FRANCISCO PA-C NPI 1841624483

NPI Information

  • NPI: 1841624483
  • Provider Name: MICHAEL THOMAS FRANCISCO, PA-C
  • Classification: Physician Assistant - 363A00000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 5777 E MAYO BLVD
    PHOENIX, AZ
    ZIP 85054
  • Phone: (480) 342-2000

Map and Directions

Get Directions

NPI Details

Michael Thomas Francisco, PA-C is a physician assistant in Phoenix, AZ with 13 years of experience. The provider is a physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician. Michael Thomas Francisco, PA-C NPI is 1841624483. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

5777 E MAYO BLVD
PHOENIX, AZ
ZIP 85054-502
Phone: (480) 342-2000
Fax: (269) 373-0123

The NPI 1841624483 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, belatacept, 1 mg (HCPCS:J0485)
  • Injection, vedolizumab, 1 mg (HCPCS:J3380)
  • Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Transfusion of blood or blood products (HCPCS:36430)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Injection, ertapenem sodium, 500 mg (HCPCS:J1335)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)

The enumeration date for this NPI number is 8/31/2013 and was last updated on 2/11/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1363A00000XPhysician Assistant5601006737MICHIGANNo
2363A00000XPhysician Assistant8193ARIZONAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.